Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

27.08

+0.70 (2.65%)

At close: Nov 14, 2025, 4:00 PM EST

28.45

+1.37 (5.06%)

After-hours: Nov 14, 2025, 7:03 PM EST

Oruka Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024
Net Income	-109.24	-91.34
Depreciation & Amortization	0.07	0.03
Loss (Gain) From Sale of Investments	-6.79	-2.45
Stock-Based Compensation	26.63	16.28
Other Operating Activities	0.53	1.74
Change in Accounts Payable	-4.9	10.35
Change in Other Net Operating Assets	4.01	2.3
Operating Cash Flow	-89.69	-63.09
Capital Expenditures	-0.18	-0.21
Investment in Securities	-434.51	-359.93
Investing Cash Flow	-434.69	-360.14
Total Debt Issued	2.27	27.25
Net Debt Issued (Repaid)	2.27	27.25
Issuance of Common Stock	207.37	454.57
Other Financing Activities	0.45	5.39
Financing Cash Flow	210.36	490.41
Net Cash Flow	-314.02	67.17
Free Cash Flow	-89.87	-63.3
Free Cash Flow Per Share	-2.09	-3.77
Change in Working Capital	-0.89	12.64

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q